07:17 AM EDT, 03/24/2026 (MT Newswires) -- Julie Rubinstein, President and COO, on March 19, 2026, sold 57,180 shares in Adaptive Biotechnologies ( ADPT ) for $769,643. Following the Form 4 filing with the SEC, Rubinstein has control over a total of 481,906 common shares of the company, with 481,906 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1478320/000178066426000014/xslF345X05/form4.xml